ACOs and CBOs: Don’t get lost in the gap! Process improvement expert Jessica Carpenter explains how the gap between your organization’s policies and everyday practices is where efficiency and compliance can fall or become lost. Read Jessica’s blog to learn the three key steps to achieve process improvement and deliver better results on a more consistent basis.
Even though most Medicaid Accountable Care Organizations (ACOs) are not responsible for the cost of dental office visits, they can still improve patient care and reduce their costs by focusing on oral health. Find out how in this blog post from Senior Associate of Health Law & Policy Rachel Gershon.
Want to know key facts about MassHealth, the Massachusetts Medicaid program that covers over 1.8 Million members? Read this blog to learn the three major themes of a Blue Cross Blue Shield Massachusetts Foundation report from our Health Law & Policy experts.
If Managed Care Organizations & Accountable Care Organizations invested in school nutrition programs now to ensure lunches are up to Health Hunger-Free Kids Act standards, it may cut healthcare costs tomorrow. Andrew Falacci blogs on the importance of instilling healthy eating habits in youth to “avoid costs and poor health in the future."
Would ending some drug rebates for PBMs lower list prices and patient out-of-pocket-costs? Our pharmacy experts Mckenzie Taylor & Stephanie Tran explore a proposed rule from the Department of Health and Human Services that would change the Medicare & Medicaid pricing system.
Pharmacists play a vital role in the patient care process that is often overlooked. Clinical pharmacy expert Ashley Chiara blogs about how they connect the dots between prescribers and patients, impacting clinical and economic outcomes.
Comprehensive care for children – including greater attention to behavioral health, socio-emotional development, and strong family relationships – may hold the key to lifelong health and well-being.
Prohibiting gag clauses could help lower consumer out-of-pocket pharmacy costs - if Pharmacy Benefits Managers don't raise prices to make-up the difference. Mylissa Price closes our blog series on President Trump's Blueprint to Lower Drug Costs in this final entry.
Decoding the critical differences between state Medicaid programs can be a frustrating task for policymakers & researchers alike. Health policy expert Rachel Gershon simplifies things by shedding light on helpful informational resources in a new blog post.
The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for incentives to lower drug list prices, including removing rebates. Our clinical consultant Stephanie Tran continues our pharmacy blog series with an assessment of this potential change & its impacts.